FDA DIETARY FIBER HEALTH CLAIMS CONFERENCE SET FOR MAY 12-13
This article was originally published in The Tan Sheet
FDA DIETARY FIBER HEALTH CLAIMS CONFERENCE SET FOR MAY 12-13 will address "the criteria for determining whether significant scientific agreement" on the relationship between dietary fiber and cancer or heart disease exists, FDA announced in an April 7 Federal Register notice. FDA said it plans to divide the meeting into "four major parts" -- an opening and overview of dietary fiber, a discussion of dietary fiber and heart disease, a discussion on dietary fiber and cancer, and a discussion of the criteria for determining significant scientific agreement on dietary fiber health claims. A similar public conference took place in November to address antioxidant health claims ("The Tan Sheet" Nov. 8, 1993, pp. 15-21).
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC